Diagnamed Holdings Corp. is a developing a platform of software-based prescription digital therapeutic products (“PDT Products”) with the potential to improve early detection of neurological disorders, overall patient health and lower healthcare costs. The Company’s PDT Products include: (1) BrainYear™, an electroencephalogram-based (“EEG”) machine-learning solution to detect an individual’s brain age for use in clinic and at-home; and (2) BrainTremor™, a wearable device to detect tremors and brain activity for neurological disorders by EEG. The Company is conducting research and development of digital therapeutics applications with the intent to commercialize its PDT Products in the United States and currently outsources its research and development in the U.S. and Canada. The Company’s goal is to complete the development of a prototype of BrainYear™ and BrainTremor™ for clinical research, and ultimately commercialize these products initially in the United States.